Schede Farmaci
Consulta le schede farmaci (fino al 2019) :
- A07AA12 – Fidaxomicina (DIFICLIR)
- A07FA – Enterogermina
- A10AE04 – Insulina glargine (ABASAGLAR)
- B01AC24 – Ticagrelor (BRILIQUE)
- B01AX06 – Apixaban (ELIQUIS)
- B02BX – Eltrombopag (REVOLADE)
- B05BA10 – Numeta (sacca nutrizione parenterale)
- B05XB02 – Glutamina (DIPEPTIVEN)
- C01DA – Nitroglicerina spray (NATISPRAY)
- C01EB21 – Regadenoson (RAPISCAN)
- C05CX – Escina e fosfatidilcolina (ESSAVEN GEL)
- C09BB – Associazione enalaprillercanidipina (ZANIPRIL)
- C10AX14 – Alirocumab (PRALUENT)
- C10AX14 – Evolocumab (REPATHA)
- D03BA52 – Collagenasi Cloramfenicolo (IRUXOL)
- D06BX02 – Ingenolo mebutato (PICATO)
- G02AD – Misoprostolo (MYSODELLE)
- G03AC – Etonogestrel (NEXPLANON)
- H01BB03 – Carbetocina (DURATOCIN)
- J01AA – Minociclina orale (MINOCIN)
- J01DI02 – Ceftarolina fosamil (ZINFORO)
- J04AK05 – Bedaquilina (SIRTURO)
- J06BB – Immunoglobulina antiepatite B (IGANTIBE)
- J07BB – Vaccino influenzale (FLUARIX ed altri)
- L01BB – Cladribina (LITAK)
- L01BC59 – Trifluridina-tipiracil (LONSURF)
- L01CA – Vinflunina (JAVLOR)
- L01CD04 – Cabazitaxel (JEVTANA)
- L01XC07 – Bevacizumab (AVASTIN)
- L01XC12 – Brentuximab vedotin (ADCETRIS)
- L01XC13 – Pertuzumab (PERJETA)
- L01XC14 – Trastuzumab emtansine (KADCYLA)
- L01XC18 – Pembrolizumab (KEYTRUDA)
- L01XC21 – Ramucirumab (CYRAMZA)
- L01XC27 – Olaratumab (LATRUVO)
- L01XE13 – Afatinib (GIOTRIF)
- L01XE14 – Bosutinib (BOSULIF)
- L01XE16 – Crizotinib (XALKORI)
- L01XE21 – Regorafenib (STIVARGA)
- L01XE23 – Dabrafenib (TAFINLAR)
- L01XE24 – Ponatinib (ICLUSIG)
- L01XE33 – Palbociclib (IBRANCE)
- L01XE35 – Osimertinib (TAGRISSO)
- L01XX41 – Eribulina (HALAVEN)
- L01XX43 – Vismodegib (ERIVEDGE)
- L01XXX – Decitabina (DACOGEN)
- L01XXX- Aflibercept (ZALTRAP)
- L02BB – Enzalutamide (XTANDI)
- L02BX02 – Degarelix (FIRMAGON)
- L04AA- Fingolimod (GILENYA)
- L04AA29 – Tofacitinib (XELJANZ)
- L04AA37 – Baricitinib (OLUMIANT)
- L04AB – Certolizumab (CIMZIA)
- L04AB01 – Etanercept (BENEPALI)
- L04AB02 – Infliximab (INFLECTRA)
- L04AX06 – Pomalidomide (IMNOVID)
- M01AH – Parecoxib parenterale (DYNASTAT)
- M04AA03 – Febuxostat (ADENURIC)
- M09AX01 – Acido ialuronico sale sodico (HYALGAN)
- N01BB52 – Lidocaina 70 mg – Tetracaina 70 mg (RALYDAN)
- N01BX – Capsaicina (QUTENZA)
- N02AA – Ossicodone associato a naloxone (TARGIN)
- N02AB – Fentanil (INSTANYL)
- N02AB – Fentanil (PECFENT)
- N02CX07 – Erenumab (AIMOVIG)
- N05A4- Asenapina (SYCREST)
- N05AX01 – Loxapina (ADASUVE)
- N05CD08 – Midazolam (BUCCOLAM)
- N05CM18 – Dexmedetomidina (DEXDOR)
- N06AX – Agomelatina (VALDOXAN)
- N07BC04 – Lofexidina cloridrato (DIMATEX)
- N07XX – Amifampridina (FIRDAPSE)
- N07XX09 – Dimetilfumarato (TECFIDERA)
- R03AK10 – Fluticasone furoato vilanterolo (RELVAR ELLIPTA -REVINTY ELLIPTA)
- R03BB05 – Aclidinio bromuro (EKLIRA GENUAIR)
- R03BB06 – Glicopirronio (SEEBRI BREEZHALER)
- R06AX – Rupatidina (RUPAFIN, PAFINUR)
- S01AX22 – Moxifloxacina (VIGAMOX)
- S01BA – Desametasone intravitreale (OZURDEX)
- S01BA – Triamcinolone acetonide (TAIOFTAL)
- S01BC10 – Nepafenac (NEVANAC)
- S01ED51 – Tafluprost timololo (LOYADA)
- S01FA – Tropicamide e fenilefrina (MYDRIASERT)
- S01LA05 – Aflibercept (EYLEA)
- S01XA22 – Ocriplasmina (JETREA)
Ultimo aggiornamento
1 Ottobre 2021, 10:19